Hematology NewsTreatment of choice for NLPHL? Involved-field RT aloneAugust 5, 2015Indolent LymphomaLymphoma & Plasma Cell Disorders
Oncology PracticeDoxorubicin, radiation doses predict heart risk in lymphoma survivorsJuly 14, 2015Patient & Survivor CareLymphoma & Plasma Cell DisordersIndolent LymphomaTransfusion Medicine
Hematology NewsInterim PET results guide ongoing therapy in Hodgkin lymphomaJuly 8, 2015Indolent LymphomaHodgkin Lymphoma
Oncology PracticeInterim PET provides limited prognostic value for diffuse large B-cell lymphomaJuly 7, 2015Lymphoma & Plasma Cell DisordersIndolent LymphomaB Cell Lymphoma
Hematology NewsSecond pathology review boosts diagnostic accuracy in lymphomaJuly 7, 2015Lymphoma & Plasma Cell DisordersIndolent LymphomaFollicular Lymphoma
Oncology PracticeEarly relapse signals high mortality in follicular lymphomaJuly 2, 2015Lymphoma & Plasma Cell DisordersIndolent LymphomaFollicular Lymphoma
Oncology PracticeVIDEO: Rituximab-refractory indolent NHL yields to combo treatmentJune 1, 2015Lymphoma & Plasma Cell DisordersIndolent Lymphoma
Hematology NewsIbrutinib highly active against refractory Waldenstrom’s macroglobulinemiaApril 8, 2015Indolent Lymphoma
The Journal of Community and Supportive OncologyDiffuse large B-cell lymphoma of the lung in a 63-year-old man with left flank painDecember 11, 2013Lymphoma & Plasma Cell DisordersIndolent LymphomaB Cell Lymphoma
Hematology NewsNo survival benefit for routine surveillance scans in classical Hodgkin diseaseJuly 8, 2013Translational ResearchTransfusion MedicineIndolent LymphomaHodgkin Lymphoma
